369 related articles for article (PubMed ID: 36369636)
1. Association Between Decreased Srpk3 Expression and Increased Substantia Nigra Alpha-Synuclein Level in an MPTP-Induced Parkinson's Disease Mouse Model.
Seo MH; Yeo S
Mol Neurobiol; 2023 Feb; 60(2):780-788. PubMed ID: 36369636
[TBL] [Abstract][Full Text] [Related]
2.
Seo MH; Yeo S
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502283
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of serum- and glucocorticoid-inducible kinase 1 (SGK1) promotes alpha-synuclein increase related with down-regulation of dopaminergic cell in the Substantia Nigra of chronic MPTP-induced Parkinsonism mice and in SH-SY5Y cells.
Yeo S; Sung B; Hong YM; van den Noort M; Bosch P; Lee SH; Song J; Park SK; Lim S
Gene; 2018 Jun; 661():189-195. PubMed ID: 29604467
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of natural resistance-associated macrophage protein-1 (Nramp1) is associated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)/1-methyl-4-phenylpyridinium (MPP
Wu KC; Liou HH; Lee CY; Lin CJ
Neuropathol Appl Neurobiol; 2019 Feb; 45(2):157-173. PubMed ID: 29679389
[TBL] [Abstract][Full Text] [Related]
5. Decrease in
Han S; Seo MH; Lim S; Yeo S
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884422
[TBL] [Abstract][Full Text] [Related]
6. The Involvement of Progranulin for α-Synuclein Reduction through Autolysosome Formation.
Fujimori H; Ohba T; Nakamura S; Shimazawa M; Hara H
Biol Pharm Bull; 2023; 46(8):1032-1040. PubMed ID: 37532554
[TBL] [Abstract][Full Text] [Related]
7. Acupuncture Inhibits the Increase in Alpha-Synuclein by Modulating SGK1 in an MPTP Induced Parkinsonism Mouse Model.
Yeo S; Lim S
Am J Chin Med; 2019; 47(3):527-539. PubMed ID: 30966771
[TBL] [Abstract][Full Text] [Related]
8. Association between Decreased ITGA7 Levels and Increased Muscle α-Synuclein in an MPTP-Induced Mouse Model of Parkinson's Disease.
Han S; Lim S; Yeo S
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628462
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA NEAT1 mediates the toxic of Parkinson's disease induced by MPTP/MPP+ via regulation of gene expression.
Liu Y; Lu Z
Clin Exp Pharmacol Physiol; 2018 Aug; 45(8):841-848. PubMed ID: 29575151
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of osmotin in Parkinson's disease-associated pathology via the AdipoR1/MAPK/AMPK/mTOR signaling pathways.
Park JS; Choe K; Lee HJ; Park TJ; Kim MO
J Biomed Sci; 2023 Aug; 30(1):66. PubMed ID: 37568205
[TBL] [Abstract][Full Text] [Related]
11. Artemisia Leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy/mitophagy clearance in both in vitro and in vivo models of MPP+/MPTP-induced Parkinson's disease.
Wu LK; Agarwal S; Kuo CH; Kung YL; Day CH; Lin PY; Lin SZ; Hsieh DJ; Huang CY; Chiang CY
Phytomedicine; 2022 Sep; 104():154250. PubMed ID: 35752074
[TBL] [Abstract][Full Text] [Related]
12. Acupuncture Inhibits the Increase in Alpha-Synuclein in Substantia Nigra in an MPTP- Induced Parkinsonism Mouse Model.
Yeo S; Song J; Lim S
Adv Exp Med Biol; 2020; 1232():401-408. PubMed ID: 31893437
[TBL] [Abstract][Full Text] [Related]
13. Orexin B protects dopaminergic neurons from 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity associated with reduced extracellular signal-regulated kinase phosphorylation.
Ma X; Cao F; Cui J; Li X; Yin Z; Wu Y; Wang Q
Mol Biol Rep; 2024 May; 51(1):669. PubMed ID: 38787465
[TBL] [Abstract][Full Text] [Related]
14. Gintonin Mitigates MPTP-Induced Loss of Nigrostriatal Dopaminergic Neurons and Accumulation of α-Synuclein via the Nrf2/HO-1 Pathway.
Jo MG; Ikram M; Jo MH; Yoo L; Chung KC; Nah SY; Hwang H; Rhim H; Kim MO
Mol Neurobiol; 2019 Jan; 56(1):39-55. PubMed ID: 29675576
[TBL] [Abstract][Full Text] [Related]
15. Association of decreased triadin expression level with apoptosis of dopaminergic cells in Parkinson's disease mouse model.
Seo MH; Lim S; Yeo S
BMC Neurosci; 2021 Nov; 22(1):65. PubMed ID: 34736417
[TBL] [Abstract][Full Text] [Related]
16. Apelin-36 mitigates MPTP/MPP
Zhu J; Dou S; Wang C; Jiang Y; Wang C; Cheng B
Brain Res; 2019 Oct; 1721():146334. PubMed ID: 31306618
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
Kanagaraj N; Beiping H; Dheen ST; Tay SS
Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
[TBL] [Abstract][Full Text] [Related]
18. The Potential Role of Toll-Like Receptor 4 in Mediating Dopaminergic Cell Loss and Alpha-Synuclein Expression in the Acute MPTP Mouse Model of Parkinson's Disease.
Mariucci G; Pagiotti R; Galli F; Romani L; Conte C
J Mol Neurosci; 2018 Apr; 64(4):611-618. PubMed ID: 29589201
[TBL] [Abstract][Full Text] [Related]
19. Association of increase in Serping1 level with dopaminergic cell reduction in an MPTP-induced Parkinson's disease mouse model.
Seo MH; Yeo S
Brain Res Bull; 2020 Sep; 162():67-72. PubMed ID: 32485229
[TBL] [Abstract][Full Text] [Related]
20. The peptidyl-prolyl isomerase Pin1 up-regulation and proapoptotic function in dopaminergic neurons: relevance to the pathogenesis of Parkinson disease.
Ghosh A; Saminathan H; Kanthasamy A; Anantharam V; Jin H; Sondarva G; Harischandra DS; Qian Z; Rana A; Kanthasamy AG
J Biol Chem; 2013 Jul; 288(30):21955-71. PubMed ID: 23754278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]